Chief Executive Officer
Mr. Vickus is the CEO of Angioslide and has over 10 years of personal hands-on experience in the development, management and commercialization of medical devices. Eran joined Angioslide in 2010. As VP Commercial, he led the strategic development of US & OUS markets, cultivated a strong network of relationships with physicians and partners as well as leading the company’s sales, marketing, reimbursement and clinical activities. Prior to Angioslide, Eran served in various leadership sales, clinical, marketing, and product development positions for UltraShape Medical (acquired by Syneron) Ltd, KST Dynamics and Andante Medical Inc.. Eran’s motto is “Build products that matter” and has significant experience in the commercialization of multi-disciplinary medical systems, and presently focused on providing physicians with smart products that potentially reduce the risks associated with thromboembolic loads during endovascular interventions. Mr. Vickus holds an Executive MBA from Tel Aviv University and a B.Sc. degree in Biomedical Engineering from Ben-Gurion University in Israel.
Mr. Avitov is a consultant to Angioslide management team, after serving 3.5 years as Angioslide CEO between 2011-2015. Prior to Angioslide he served as an EVP at XT Investments ech, one of Israel’s leading private equity firms, heading the healthcare team. Prior to that, he served as CEO of Naiot Venture Accelerator, and as General Manager of Rimlon, a medical device company in the orthopedics field. At XT and Naiot he led various investments in innovative healthcare technologies and played an active role in their day-to-day management. In 2007 Mr. Avitov co-founded PainReform, a startup dedicated to developing drug reformulations in the field of pain management, currently in phase II. Mr. Avitov holds a bachelor's degree in Economics and Management, and a master's degree from the Department of Industrial Engineering and Management at the Technion – Israel Institute of Technology in Haifa, Israel.